Drug Trials Snapshot: LIVTENCITY (maribavir)

Drug Trials Snapshot: LIVTENCITY (maribavir) LIVTENCITY is a prescription medicine used to treat cytomegalovirus (CMV) infection and disease in adults and children 12 years of age and older and weighing at least 77 pounds (35 kg) who have received a solid organ or stem cell transplant, when their infection or disease does not respond to treatment with ganciclovir, valganciclovir, cidofovir, or foscarnet. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-livtencity